New drug cocktail aims to tame tough thyroid cancer
NCT ID NCT04061980
Summary
This study is testing whether a combination of targeted drugs, with or without an immunotherapy drug, can help control advanced thyroid cancer that has spread and no longer responds to standard radioactive iodine treatment. It is for patients whose cancer has a specific genetic change called a BRAF V600 mutation. The goal is to see if these drug combinations are safe and can shrink tumors or slow their growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY THYROID GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
Conditions
Explore the condition pages connected to this study.